Glucose, VEGF-A, and diabetic complications

doi:10.1016/S0002-9440(10)64066-7

Review

. 2001 Apr;158(4):1181-4.

doi: 10.1016/S0002-9440(10)64066-7.

Glucose, VEGF-A, and diabetic complications

L E Benjamin¹

Affiliations

Affiliation

¹ Depatrtment of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School. 300 Brookline Ave., Boston, MA 02215, USA. lbenjamin@caregroup.harvard.edu

PMID: 11290533
PMCID: PMC1891912
DOI: 10.1016/S0002-9440(10)64066-7

Review

Glucose, VEGF-A, and diabetic complications

L E Benjamin. Am J Pathol. 2001 Apr.

. 2001 Apr;158(4):1181-4.

doi: 10.1016/S0002-9440(10)64066-7.

Author

L E Benjamin¹

Affiliation

¹ Depatrtment of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School. 300 Brookline Ave., Boston, MA 02215, USA. lbenjamin@caregroup.harvard.edu

PMID: 11290533
PMCID: PMC1891912
DOI: 10.1016/S0002-9440(10)64066-7

No abstract available

PubMed Disclaimer

Comment on

Hyperglycemia-induced vasculopathy in the murine conceptus is mediated via reductions of VEGF-A expression and VEGF receptor activation.
Pinter E, Haigh J, Nagy A, Madri JA. Pinter E, et al. Am J Pathol. 2001 Apr;158(4):1199-206. doi: 10.1016/S0002-9440(10)64069-2. Am J Pathol. 2001. PMID: 11290536 Free PMC article.

Cited by

Peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) enhances engraftment and angiogenesis of mesenchymal stem cells in diabetic hindlimb ischemia.
Lu D, Zhang L, Wang H, Zhang Y, Liu J, Xu J, Liang Z, Deng W, Jiang Y, Wu Q, Li S, Ai Z, Zhong Y, Ying Y, Liu H, Gao F, Zhang Z, Chen B. Lu D, et al. Diabetes. 2012 May;61(5):1153-9. doi: 10.2337/db11-1271. Epub 2012 Jan 20. Diabetes. 2012. PMID: 22266669 Free PMC article.
The role of dysregulated glucose metabolism in epithelial ovarian cancer.
Kellenberger LD, Bruin JE, Greenaway J, Campbell NE, Moorehead RA, Holloway AC, Petrik J. Kellenberger LD, et al. J Oncol. 2010;2010:514310. doi: 10.1155/2010/514310. Epub 2010 Feb 17. J Oncol. 2010. PMID: 20182531 Free PMC article.
Integrative analysis of gene expression, protein abundance, and metabolomic profiling elucidates complex relationships in chronic hyperglycemia-induced changes in human aortic smooth muscle cells.
Bohara S, Bagheri A, Ertugral EG, Radzikh I, Sandlers Y, Jiang P, Kothapalli CR. Bohara S, et al. J Biol Eng. 2024 Oct 29;18(1):61. doi: 10.1186/s13036-024-00457-w. J Biol Eng. 2024. PMID: 39473010 Free PMC article.
Pericytes from infantile hemangioma display proangiogenic properties and dysregulated angiopoietin-1.
Boscolo E, Mulliken JB, Bischoff J. Boscolo E, et al. Arterioscler Thromb Vasc Biol. 2013 Mar;33(3):501-9. doi: 10.1161/ATVBAHA.112.300929. Epub 2013 Jan 3. Arterioscler Thromb Vasc Biol. 2013. PMID: 23288163 Free PMC article.
Single Cell Analysis Identifies the miRNA Expression Profile of a Subpopulation of Muscle Precursor Cells Unique to Humans With Type 2 Diabetes.
Henriksen TI, Heywood SE, Hansen NS, Pedersen BK, Scheele CC, Nielsen S. Henriksen TI, et al. Front Physiol. 2018 Jul 11;9:883. doi: 10.3389/fphys.2018.00883. eCollection 2018. Front Physiol. 2018. PMID: 30050458 Free PMC article.

See all "Cited by" articles

References

1. Pinter E, Haigh J, Nagy A, Madri J: Hyperglycemia-induced vasculopathy in the murine conceptus is mediated via reductions of VEGF-A expression and VEGF receptor activation. Am J Pathol 2001, 158:1199-1206 - PMC - PubMed
1. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, King GL: Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994, 331:1480-1487 - PubMed
1. Adamis AP, Miller JW, Bernal MT, D’Amico DJ, Folkman J, Yeo TK, Yeo KT: Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 1994, 118:445-450 - PubMed
1. Boulton M, Foreman D, Williams G, McLeod D: VEGF localisation in diabetic retinopathy. Br J Ophthalmol 1998, 82:561-568 - PMC - PubMed
1. Burgos R, Simo R, Audi L, Mateo C, Mesa J, Garcia-Ramirez M, Carrascosa A: Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy. Diabetologia 1997, 40:1107-1109 - PubMed

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information

[1] Pinter E, Haigh J, Nagy A, Madri J: Hyperglycemia-induced vasculopathy in the murine conceptus is mediated via reductions of VEGF-A expression and VEGF receptor activation. Am J Pathol 2001, 158:1199-1206 - PMC - PubMed

[2] Pinter E, Haigh J, Nagy A, Madri J: Hyperglycemia-induced vasculopathy in the murine conceptus is mediated via reductions of VEGF-A expression and VEGF receptor activation. Am J Pathol 2001, 158:1199-1206 - PMC - PubMed

[3] Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, King GL: Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994, 331:1480-1487 - PubMed

[4] Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, King GL: Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994, 331:1480-1487 - PubMed

[5] Adamis AP, Miller JW, Bernal MT, D’Amico DJ, Folkman J, Yeo TK, Yeo KT: Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 1994, 118:445-450 - PubMed

[6] Adamis AP, Miller JW, Bernal MT, D’Amico DJ, Folkman J, Yeo TK, Yeo KT: Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 1994, 118:445-450 - PubMed

[7] Boulton M, Foreman D, Williams G, McLeod D: VEGF localisation in diabetic retinopathy. Br J Ophthalmol 1998, 82:561-568 - PMC - PubMed

[8] Boulton M, Foreman D, Williams G, McLeod D: VEGF localisation in diabetic retinopathy. Br J Ophthalmol 1998, 82:561-568 - PMC - PubMed

[9] Burgos R, Simo R, Audi L, Mateo C, Mesa J, Garcia-Ramirez M, Carrascosa A: Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy. Diabetologia 1997, 40:1107-1109 - PubMed

[10] Burgos R, Simo R, Audi L, Mateo C, Mesa J, Garcia-Ramirez M, Carrascosa A: Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy. Diabetologia 1997, 40:1107-1109 - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Glucose, VEGF-A, and diabetic complications

Affiliation

Glucose, VEGF-A, and diabetic complications

Author

Affiliation

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical